Aura Biosciences Inc (AURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | 12-2020 | 09-2020 | |
| Operating Expenses | 5,927 | 0 | 3,631 |
| Operating Income | -5,927 | N/A | -3,631 |
| Pre-tax Income | -5,927 | 0 | -3,631 |
| Net Income Continuous | -5,927 | N/A | -3,631 |
| Net Income | $-5,927 | $N/A | $-3,631 |
| EPS Basic Total Ops | -20.62 | N/A | -14.81 |
| EPS Basic Continuous Ops | -14.82 | N/A | -9.64 |
| EPS Diluted Total Ops | -20.62 | N/A | -14.81 |
| EPS Diluted Continuous Ops | -14.82 | N/A | -9.64 |
| EBITDA(a) | $-5,742 | $N/A | $-3,631 |